Asset Details
Do you wish to reserve the book?
Meningococcal Vaccine in Mali and Gambia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Meningococcal Vaccine in Mali and Gambia
Do you wish to request the book?
Meningococcal Vaccine in Mali and Gambia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Meningococcal Vaccine in Mali and Gambia
2023
Overview
To the Editor:
Haidara et al. (May 25 issue)
1
report that the immune responses with the NmCV-5 vaccine were noninferior to those with the licensed MenACWY-D vaccine, a result that may allow licensing of the NmCV-5 vaccine for wider use. The results of this trial are important, given the additional humoral immunity shown against serogroup X isolates of
Neisseria meningitidis
and the potential affordability of this pentavalent vaccine.
1
The prevalence of human immunodeficiency virus (HIV) infection in Gambia and Mali (approximately 1%) is low as compared with that in other countries in Africa but is considered to be high according . . .
Publisher
Massachusetts Medical Society
